drugset / Trial / NCT03476018
Trial to Optimally Show the Pharmacological Action of Z-100
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The objective of this clinical trial is to evaluate the change of the immunological parameter levels in FIGO stage IIIB cervical cancer subjects by administration of Z-100
Timeline
- Start
- 2018-04-02
- Primary completion
- 2021-07-20
- Completion
- 2021-12-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Z-100 | Unknown | 0.2 ug | — |
| Subject | Z-100 | Unknown | 2 ug | — |
| Subject | Z-100 | Unknown | 20 ug | — |